Restaurant Brands International Stock Forum

Garbage stock; completely worthless; bad-quality products with exploited workers; and they don't want to change anything; All Bill Ackman concerns is taking profit and run
$Restaurant Brands International Inc (QSR.CA)$ $Restaurant Brands International (QSR.US)$

Bill Ackman's hedge fund, Pershing Square, revealed its Q2 13F filing on Wednesday, showcasing new stakes in $Nike (NKE.US)$ and Canadian investment firm $Brookfield (BN.US)$/ $Brookfield Corp (BN.CA)$ . Meanwhile, the hedge fund titan has slashed his holdings in $Chipotle Mexican Grill (CMG.US)$, $Restaurant Brands International (QSR.US)$/ $Restaurant Brands International Inc (QSR.CA)$ , the parent company of Burger King an...

Morning Movers
Gapping up
$Eli Lilly and Co (LLY.US)$ 's stock increased by 11.5% after the pharmaceutical company boosted its annual profit forecast, with sales of its weight-loss drug Zepbound surpassing the $1 billion mark in a single quarter for the first time.
$Apple (AAPL.US)$ 's stock edged up by 0.1% following a report from CNBC that the tech giant may introduce a charge of up to $20 for advanced artificial intelligence f...

$Restaurant Brands International (QSR.US)$
Restaurant Brands International Announces Investments to Drive Growth in China
Restaurant Brands International (RBI) has announced two significant transactions in China. RBI will acquire Popeyes China for an enterprise value of $15 million, which includes 14 restaurants in Shanghai. This move aims to accelerate growth in the Chinese market, with plans for local team investments and further restaurant development. Additionally, RBI and Cartesian Capit...

Morning Movers
Gapping up
$Eli Lilly and Co (LLY.US)$ The pharmaceutical company's stock increased by 6.7% following its report of stronger-than-expected earnings for the first quarter and raised its full-year guidance, fueled by robust sales of its diabetes medication Mounjaro and the newly released weight loss treatment Zepbound.
$3M (MMM.US)$ The industrial conglomerate's shares jumped 7.4% after surpassing analysts' expectation...